SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-023605
Filing Date
2018-09-26
Accepted
2018-09-26 17:22:56
Documents
3
Period of Report
2018-09-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K clsd-8k_20180926.htm 8-K 37039
2 EX-99.1 clsd-ex991_22.htm EX-99.1 15261
3 GRAPHIC gt0solqibmhw000001.jpg GRAPHIC 3655
  Complete submission text file 0001564590-18-023605.txt   58787
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: GA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37783 | Film No.: 181088686
SIC: 2834 Pharmaceutical Preparations